Dry Eye Disease

More than a decade ago, the International Task Force Delphi Panel on Dry Eye identified autologous serum eye drops as a recommended treatment for patients with severe or chronic dry eye symptoms and/or moderate to marked staining.

OC-01 nasal spray, which was recently approved by the FDA, is an effective treatment for patients with varying severities of dry eye disease, according to a speaker at the European Society of Cataract and Refractive Surgeons meeting.

The FDA approved Tyrvaya nasal spray for the treatment of signs and symptoms of dry eye disease, according to a press release from Oyster Point Pharma.

Doctor: “We need to start doing InflammaDry on our dry eye disease patients again. I haven’t seen an ID in weeks. When did we quit using it?”

The first three installments of our blog on the complex cornea provided an overview of considerations in these patients when they present for cataract surgery.

When working with patients who are dissatisfied with their multifocal IOLs after cataract surgery, there are several factors to address before assuming the patient is visually demanding, according to a speaker.

Study results from a promising dry eye disease candidate and a blog about corneal cross-linking are two of the best-performing cornea/external disease items from September.

NOV03 met all primary and secondary sign and symptom endpoints in a second phase 3 trial investigating the therapy for dry eye disease treatment, according to a press release from Bausch + Lomb and Novaliq.

NCX 4251 did not meet the primary or secondary efficacy endpoints in a phase 2b clinical trial investigating the ophthalmic suspension in patients with acute exacerbations of blepharitis, according to a press release from Nicox.

Sigh. Summertime in the northern latitudes is a fleeting joy.